Takeda Pharmaceutical Co Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K reports the resolutions passed at the 146th Ordinary General Meeting of Shareholders held on June 29, 2022. The filing covers matters reported on for the 145th fiscal year (April 1, 2021 to March 31, 2022) and corporate governance decisions made on the meeting date.
Key Financial Metrics
The filing references the Consolidated and Unconsolidated Financial Statements for the 145th fiscal year but does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity within this document. The only specific financial figure disclosed is the year-end dividend appropriation of 90 yen (JPY90.00) per share.
Material Changes and Resolutions
- Dividend Approval: Shareholders approved the appropriation of surplus, setting the year-end dividend at 90 yen per share.
- Board Elections: Eleven Directors who are not Audit and Supervisory Committee Members were elected, including the re-election of President Christophe Weber and the new election of Masami Iijima, John Maraganore, and Michel Orsinger. Four Audit and Supervisory Committee Members were also elected, with Yoshiaki Fujimori and Kimberly A. Reed newly elected.
- Executive Compensation: Approval was granted to pay bonuses totaling up to 500 million yen to three specific Directors (excluding overseas and External Directors) in office at the end of the fiscal year.
- Articles of Incorporation Amendment: The company amended its Articles to replace internet disclosure provisions with new measures for the electronic provision of shareholder meeting information, effective September 1, 2022.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, outlook, specific risks, or contingencies. It is strictly a notice of shareholder meeting resolutions.
Investor Verification Checklist
- Verify the full Consolidated Financial Statements for the fiscal year ended March 31, 2022, as detailed metrics are not included in this 6-K.
- Confirm the exact composition of the newly elected Board of Directors and Audit and Supervisory Committee.
- Review the specific terms of the Articles of Incorporation amendment regarding electronic document delivery effective September 1, 2022.
- Check subsequent filings for the actual payout amount of the approved 500 million yen director bonus pool.